Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2019-02-07 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROCHES-PREMARIE-ANDILLE (86340), Vienne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES ROCHES-PREMARIE : revenue, balance sheet and financial ratios
PHARMACIE DES ROCHES-PREMARIE is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROCHES-PREMARIE-ANDILLE (86340),
this company of category PME
shows in 2022 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES ROCHES-PREMARIE (SIREN 848163994)
Indicator
2023
2022
2021
2020
Revenue
N/C
1 315 302 €
N/C
N/C
Net income
43 812 €
31 776 €
68 329 €
64 718 €
EBITDA
N/C
68 890 €
N/C
N/C
Net margin
N/C
2.4%
N/C
N/C
Revenue and income statement
Im Jahr 2023 erzielt PHARMACIE DES ROCHES-PREMARIE ein positives Nettoergebnis von 44 k€. Entwicklung 2020-2023: 65 k€ -> 44 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
43 812 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 232%. Kritische Situation: Die Schulden übersteigen das Eigenkapital erheblich. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 25%. Das Gleichgewicht zwischen Eigenkapital und Schulden ist zufriedenstellend.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
232.004%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.342%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES ROCHES-PREMARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
Debt ratio
708.938
411.063
309.057
232.004
Financial autonomy
10.605
17.009
21.012
25.342
Repayment capacity
None
None
12.599
None
Cash flow / Revenue
None%
None%
4.002%
None%
Sector positioning
Verschuldungsgrad
232.02023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
Im Jahr 2023 liegt über dem Median der Branche das verschuldungsgrad von PHARMACIE DES ROCHES-PREM... (232.00). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Finanzielle Autonomie
25.34%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
Im Jahr 2023 liegt unter dem Median der Branche das finanzielle autonomie von PHARMACIE DES ROCHES-PREM... (25.3%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Eine Verbesserung würde die Wettbewerbsposition stärken.
Rückzahlungsfähigkeit
12.6 ans2022
2022
Q1: 1.29 ans
Med: 3.55 ans
Q3: 6.63 ans
Average
Im Jahr 2022 liegt über dem Median der Branche das rückzahlungsfähigkeit von PHARMACIE DES ROCHES-PREM... (12.6 ans). Dieses Verhältnis gibt die Anzahl der Jahre an, die zur Rückzahlung der Schulden mit dem Cashflow benötigt werden. Eine Reduzierung könnte die finanzielle Stärke verbessern.
Liquidity ratios
Die Liquiditätsquote beträgt 114.17. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
114.175
Liquidity indicators evolution PHARMACIE DES ROCHES-PREMARIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
Liquidity ratio
138.329
146.627
116.461
114.175
Interest coverage
None
None
13.417
None
Sector positioning
Liquiditätsquote
114.172023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Beobachten-7 pts over 3 years
Im Jahr 2023 liegt in den unteren 25% der Branche das liquiditätsquote von PHARMACIE DES ROCHES-PREM... (114.17). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis unter 1 kann auf potenzielle Liquiditätsspannungen hinweisen.
Zinsdeckung
13.42x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Ausgezeichnet
Im Jahr 2022 liegt in den oberen 25% der Branche das zinsdeckung von PHARMACIE DES ROCHES-PREM... (13.4x). Dieses Verhältnis gibt an, wie oft das Betriebsergebnis die Zinsaufwendungen deckt. Hohe Deckung bedeutet, dass Finanzaufwendungen die Rentabilität wenig belasten.
Working capital requirement (WCR) and payment terms
Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES ROCHES-PREMARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
Operating WCR
0 €
0 €
125 795 €
0 €
Inventory turnover (days)
0
0
35
0
Customer payment term (days)
0
0
1
0
Supplier payment term (days)
0
0
40
0
Positioning of PHARMACIE DES ROCHES-PREMARIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DES ROCHES-PREMARIE is estimated at
516 958 €
(range 314 387€ - 726 727€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
314k€516k€726k€
516 958 €Range: 314 387€ - 726 727€
NAF 5 année 2023
Valuation method used
Net Income Multiple
43 812 €
×
11.8x
=516 959 €
Range: 314 387€ - 726 728€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES ROCHES-PREMARIE with other companies in the same sector:
Frequently asked questions about PHARMACIE DES ROCHES-PREMARIE
What is the revenue of PHARMACIE DES ROCHES-PREMARIE ?
The revenue of PHARMACIE DES ROCHES-PREMARIE in 2022 is 1.3 M€.
Is PHARMACIE DES ROCHES-PREMARIE profitable?
Yes, PHARMACIE DES ROCHES-PREMARIE generated a net profit of 44 k€ in 2023.
Where is the headquarters of PHARMACIE DES ROCHES-PREMARIE ?
The headquarters of PHARMACIE DES ROCHES-PREMARIE is located in ROCHES-PREMARIE-ANDILLE (86340), in the department Vienne.
Where to find the tax return of PHARMACIE DES ROCHES-PREMARIE ?
The tax return of PHARMACIE DES ROCHES-PREMARIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES ROCHES-PREMARIE operate?
PHARMACIE DES ROCHES-PREMARIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart